- Home
- RGNX vs GGN Comparison
RGNX vs GGN Comparison
Compare RGNX & GGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- GGN
- Stock Information
- Founded
- RGNX 2008
- GGN 2005
- Country
- RGNX United States
- GGN United States
- Employees
- RGNX N/A
- GGN N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- GGN Finance/Investors Services
- Sector
- RGNX Health Care
- GGN Finance
- Exchange
- RGNX Nasdaq
- GGN Nasdaq
- Market Cap
- RGNX 661.2M
- GGN 720.5M
- IPO Year
- RGNX 2015
- GGN N/A
- Fundamental
- Price
- RGNX $13.08
- GGN $4.75
- Analyst Decision
- RGNX Strong Buy
- GGN
- Analyst Count
- RGNX 7
- GGN 0
- Target Price
- RGNX $30.00
- GGN N/A
- AVG Volume (30 Days)
- RGNX 602.9K
- GGN 397.4K
- Earning Date
- RGNX 11-06-2025
- GGN 01-01-0001
- Dividend Yield
- RGNX N/A
- GGN 10.26%
- EPS Growth
- RGNX N/A
- GGN N/A
- EPS
- RGNX N/A
- GGN N/A
- Revenue
- RGNX $155,782,000.00
- GGN N/A
- Revenue This Year
- RGNX $198.02
- GGN N/A
- Revenue Next Year
- RGNX $2.67
- GGN N/A
- P/E Ratio
- RGNX N/A
- GGN N/A
- Revenue Growth
- RGNX 74.95
- GGN N/A
- 52 Week Low
- RGNX $5.04
- GGN $3.51
- 52 Week High
- RGNX $13.93
- GGN $3.91
- Technical
- Relative Strength Index (RSI)
- RGNX 57.58
- GGN 39.54
- Support Level
- RGNX $12.66
- GGN $4.69
- Resistance Level
- RGNX $13.93
- GGN $4.80
- Average True Range (ATR)
- RGNX 0.69
- GGN 0.11
- MACD
- RGNX -0.05
- GGN -0.05
- Stochastic Oscillator
- RGNX 57.85
- GGN 15.91
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About GGN GAMCO Global Gold Natural Resources & Income Trust
GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option planning of writing (selling) covered call options on equity securities in its portfolio.